News | February 07, 2022
India grants Emergency Use Authorisation to Sputnik Light
This is the ninth Covid-19 vaccine approved in India
This is the ninth Covid-19 vaccine approved in India
ImmunIgY, has been developed by ReaGene Biosciences, Kyntox Bio and ProdigY, and is an antibody-containing beverage that can potentially prevent viral entry, regardless of vaccination or infection status
Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals
Spikevax has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union, the UK, Israel
Fiscal support in line with what is available in key innovation hubs such as USA and China will drive the next leg of drug discovery in India
Urges them to focus on tele-consultation like eSanjeevani and efficient monitoring of those in home isolation
The collaboration with Sanofi signifies a considerable investment in the UK’s Life Sciences sector and, along with other future strategic partners, has the potential to increase the pipeline of potential treatment options for a wide range of common and other life-threatening diseases
New capabilities on Philips Image Guided therapy mobile C-arm system – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment
Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation
The recommended daily dose for Ryaltris is 2 sprays in each nostril twice daily
Subscribe To Our Newsletter & Stay Updated
